Ignite Creation Date:
2025-12-25 @ 12:36 AM
Ignite Modification Date:
2026-01-01 @ 10:22 PM
Study NCT ID:
NCT05855967
Status:
COMPLETED
Last Update Posted:
2025-08-22
First Post:
2023-05-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Ixekizumab (LY2439821) in Participants Aged ≥18 Years With Moderate-to-Severe Plaque or Active Psoriatic Arthritis in India
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-06-27
Start Date Type:
ACTUAL
Primary Completion Date:
2024-08-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-09-23
Completion Date Type:
ACTUAL
First Submit Date:
2023-05-04
First Submit QC Date:
None
Study First Post Date:
2023-05-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-08-06
Results First Submit QC Date:
None
Results First Post Date:
2025-08-22
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-06
Last Update Post Date:
2025-08-22
Last Update Post Date Type:
ACTUAL